Continuation of angiotensin converting enzyme inhibitor therapy, in spite of occurrence of angioedema.
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, The Netherlands.
Seyed Hamidreza
SH
Mahmoudpour
Department of Cardiology, Division Heart and Lungs, University Medical Centre Utrecht, The Netherlands.
Folkert W
FW
Asselbergs
Department of Otorhinolaryngology, Academic Medical Center, Amsterdam, The Netherlands.
Ingrid
I
Terreehorst
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, The Netherlands.
Patrick C
PC
Souverein
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, The Netherlands.
Anthonius
A
de Boer
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, The Netherlands. Electronic address: A.H.Maitland@uu.nl.
Anke H
AH
Maitland-van der Zee
D000799:Angioedema / Q000139:chemically induced / Q000188:drug therapy* / Q000453:epidemiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D015994:Incidence; D008297:Male; D009426:Netherlands / Q000453:epidemiology; D055553:Prescription Drugs; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D055553:Prescription Drugs
Adverse drug reaction; Angiotensin converting enzyme inhibitor; Drug-induced angioedema; Prescribing pattern